Ponalrestat
Ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice
Product Specifications
CAS Number
72702-95-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
391.19
Molecular Formula
C17H12BrFN2O3
Notes
Research use only, not for human use.
Receptor
Aldose reductase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
